MedElevator Войти в исследования
← Поиск публикаций

DOI 10.6004/jnccn.2020.0011

Медицинская библиотека · Journal of the National Comprehensive Cancer Network : JNCCN · 2020

Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.

Flaig Thomas W, Spiess Philippe E, Agarwal Neeraj, Bangs Rick, Boorjian Stephen A, Buyyounouski Mark K, Chang Sam, Downs Tracy M, Efstathiou Jason A, Friedlander Terence, Greenberg Richard E, Guru Khurshid A, Guzzo Thomas, Herr Harry W, Hoffman-Censits Jean, Hoimes Christopher, Inman Brant A, Jimbo Masahito, Kader A Karim, Lele Subodh M, Michalski Jeff, Montgomery Jeffrey S, Nandagopal Lakshminarayanan, Pagliaro Lance C, Pal Sumanta K, Patterson Anthony, Plimack Elizabeth R, Pohar Kamal S, Preston Mark A, Sexton Wade J, Siefker-Radtke Arlene O, Tward Jonathan, Wright Jonathan L, Gurski Lisa A, Johnson-Chilla Alyse

СтатьяКлинические рекомендацииПеревод пока не подготовлен

Аннотация

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Bladder Cancer focuses on the clinical presentation and workup of suspected bladder cancer, treatment of non-muscle-invasive urothelial bladder cancer, and treatment of metastatic urothelial bladder cancer because important updates have recently been made to these sections. Some important updates include recommendations for optimal treatment of non-muscle-invasive bladder cancer in the event of a bacillus Calmette-Guérin (BCG) shortage and details about biomarker testing for advanced or metastatic disease. The systemic therapy recommendations for second-line or subsequent therapies have also been revised. Treatment and management of muscle-invasive, nonmetastatic disease is covered in the complete version of the NCCN Guidelines for Bladder Cancer available at NCCN.org. Additional topics covered in the complete version include treatment of nonurothelial histologies and recommendations for nonbladder urinary tract cancers such as upper tract urothelial carcinoma, urothelial carcinoma of the prostate, and primary carcinoma of the urethra.

Для цитирования: Flaig Thomas W, Spiess Philippe E, Agarwal Neeraj, Bangs Rick, Boorjian Stephen A, Buyyounouski Mark K, Chang Sam, Downs Tracy M, Efstathiou Jason A, Friedlander Terence, Greenberg Richard E, Guru Khurshid A, Guzzo Thomas, Herr Harry W, Hoffman-Censits Jean, Hoimes Christopher, Inman Brant A, Jimbo Masahito, Kader A Karim, Lele Subodh M, Michalski Jeff, Montgomery Jeffrey S, Nandagopal Lakshminarayanan, Pagliaro Lance C, Pal Sumanta K, Patterson Anthony, Plimack Elizabeth R, Pohar Kamal S, Preston Mark A, Sexton Wade J, Siefker-Radtke Arlene O, Tward Jonathan, Wright Jonathan L, Gurski Lisa A, Johnson-Chilla Alyse. Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 2020. DOI: 10.6004/jnccn.2020.0011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.